Symbol="KNTE"
AssetType="Common Stock"
Name="Kinnate BiopharmaÂ Inc"
Description="Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers. The company is headquartered in San Diego, California."
CIK="1797768"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="11975 EL CAMINO REAL, STE 101, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="96545000"
EBITDA="-132066000"
PERatio="None"
PEGRatio="None"
BookValue="4.2"
DividendPerShare="0"
DividendYield="0"
EPS="-2.71"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.307"
ReturnOnEquityTTM="-0.502"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-2.71"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="20.34"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="1.063"
EVToRevenue="-"
EVToEBITDA="-0.336"
Beta="-0.0133"
num_52WeekHigh="14.9"
num_52WeekLow="2.01"
num_50DayMovingAverage="2.876"
num_200DayMovingAverage="4.975"
SharesOutstanding="47094900"
DividendDate="None"
ExDividendDate="None"
symbol="KNTE"
open="2.07"
high="2.18"
low="2.05"
price="2.05"
volume="199139.00"
latest_trading_day="2023-08-25"
previous_close="2.07"
change="-0.02"
change_percent="-0.9662%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="88"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="12"
Volume_recent_avg="432972"
Change_recent_avg="-0.06"
Delta_recent_avg="0.34"
Variance_recent_avg="0.17"
Change_ratio_recent_avg="-1.94"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="12"
Aroon_momentum_negative="88"
image_negative_thumbnail_id_1="1159"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0193.jpeg"
image_negative_thumbnail_id_2="114"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0062.jpeg"
image_neutral_thumbnail_id_1="560"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0039.jpeg"
image_neutral_thumbnail_id_2="544"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_positive_thumbnail_id_1="699"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0009.jpeg"
image_positive_thumbnail_id_2="623"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0085.jpeg"
image_professor_thumbnail_id_1="1199"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
image_professor_thumbnail_id_2="1170"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
